The Antimicrobial Peptide LL-37 as a Predictor Biomarker for Periodontitis with the Presence and Absence of Smoking: A Case-Control Study.
Kzar. Wael Abdulazeez WA; Abbas. Raghad Fadhil RF; Hussein. Hashim Mueen HM
Key Findings
- Salivary LL‑37 is highest in non‑smoking gum‑disease patients and lowest in healthy smokers
- LL‑37 levels rise in gum disease regardless of smoking status
- Smoking reduces overall LL‑37 levels, but the protein still distinguishes disease from health
Practical Outcomes
- For biohackers, LL‑37 could be a useful marker to track gum health, but testing requires lab ELISA kits, not a DIY method. The main actionable insight is that quitting smoking may help maintain healthier LL‑37 levels and support oral health, while regular dental care remains crucial.
Summary
The study found that a natural protein called LL‑37 is higher in the saliva of people with gum disease, especially if they don’t smoke, and lower in healthy people and smokers. Smoking cuts down LL‑37 levels, but gum disease still raises them compared to healthy mouths.
Abstract
A major issue is finding a valid biomarker able to diagnose periodontal disease with the presence and absence of risk factors. Indeed, the association between smoking and periodontal diseases and its impact on the manifestation of antimicrobial peptides has been delineated in clinical and epidemiological investigations. The antimicrobial peptide cathelicidin (LL-37) is pivotal in preserving periodontal health. This investigation examines and contrasts the levels of cathelicidin in the saliva of smokers and nonsmokers of periodontitis. The study also seeks to establish this biomarker's diagnostic ability to differentiate between periodontal health and disease. The study involved the collection of unstimulated saliva samples from 160 participants, comprising 80 patients diagnosed with periodontitis (40 of whom were smokers and 40 were nonsmokers) and 80 periodontitis-free individuals (40 smokers and 40 nonsmokers). The clinical periodontal parameters were assessed, including recording the probing pocket depth, the level of clinical attachment, and the percentage of bleeding on probing. Subsequently, enzyme-linked immunosorbent assays were conducted to quantify the protein levels of LL-37 in the saliva samples obtained from the subjects mentioned above. The highest level of salivary LL-37 was found in the nonsmoker periodontitis (NSP) patients, followed by the group of smoker periodontitis (SP) and then nonsmoker healthy (NSH) group, while the lowest level was found in the healthy smoker (HS) group. At the same time, the LL-37 seems to be a very good biomarker in differentiating periodontal health from disease with the presence and absence of smoking. Periodontitis results in a significant elevation of salivary LL-37 levels in smoker and nonsmoker patients compared to healthy individuals. These levels are positively correlated with the periodontal parameter and can serve as a valuable diagnostic tool to predict periodontitis, whereas smoking significantly reduces these levels.
Study Information
pubmed
2023
2023-09-06T00:00:00.000Z
10.1155/2023/5581267
11
53